Get 20% lifetime commission for referring investors to digrin.com
here.
Innate Pharma S.A. ( IPHA) - Stock Earnings
IPHA Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -32.4 million USD | -2.4 million USD |
| 2026Q1 | -31.7 million USD | -2.4 million USD |
| 2026Q2 | -22.7 million USD | 3.6 million USD |
| 2026Q4 Est. | — | — |
IPHA Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -8.4 million USD | 57.4 million USD |
| 2024 | -51.5 million USD | 13.1 million USD |
| 2025 | -57.7 million USD | 3.3 million USD |
| 2026 Est. | — | — |
IPHA
Price: $1.43
52 week price:
Earnings Per Share: -0.59 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: France
Volume: 6529
Market Capitalization: 149.3 million